Midkine: a promising molecule for drug development to treat diseases of the central nervous system
about
Neurobehavioral burden of multiple sclerosis with nanotheranosticsPancreatic cancerStructure and function of midkine as the basis of its pharmacological effectsStructure-function analysis of full-length midkine reveals novel residues important for heparin binding and zebrafish embryogenesisCustom 4-Plex DiLeu Isobaric Labels Enable Relative Quantification of Urinary Proteins in Men with Lower Urinary Tract Symptoms (LUTS)Transcriptional factor specificity protein 1 (SP1) promotes the proliferation of glioma cells by up-regulating midkine (MDK).Oncolytic adenoviruses: A thorny path to glioma cureRole of midkine-progranulin interaction during angiogenesis of hepatocellular carcinomaEukaryotic Expression and Purification of Native Form of Mouse Midkine from Pichia pastoris.Neurological disorders and therapeutics targeted to surmount the blood-brain barrierTumor location determines midkine level and its association with the disease progression in colorectal cancer patients: a pilot study.Current progress of RNA aptamer-based therapeutics.Quantitative Analysis of Human Pluripotency and Neural Specification by In-Depth (Phospho)Proteomic ProfilingSexually Dimorphic Gene Expression Associated with Growth and Reproduction of Tongue Sole (Cynoglossus semilaevis) Revealed by Brain Transcriptome Analysis.The role of midkine in skeletal remodelling.The midkine family of growth factors: diverse roles in nervous system formation and maintenance.The expression and function of midkine in the vertebrate retina.Targeting midkine and pleiotrophin signalling pathways in addiction and neurodegenerative disorders: recent progress and perspectives.Midkine in repair of the injured nervous systemMeasuring midkine: the utility of midkine as a biomarker in cancer and other diseases.Glycodendrimers as Chondroitin Sulfate Mimetics: Synthesis and Binding to Growth Factor Midkine.Improvement on binding of chondroitin sulfate derivatives to midkine by increasing hydrophobicity.Chondroitin Sulfate Tetrasaccharides: Synthesis, Three-Dimensional Structure and Interaction with Midkine.Antagonist activity of the antipsychotic drug lithium chloride and the antileukemic drug imatinib mesylate during glioblastoma treatment in vitro.Midkine Is a Novel Regulator of Amphetamine-Induced Striatal Gliosis and Cognitive Impairment: Evidence for a Stimulus-Dependent Regulation of Neuroinflammation by Midkine.The signal peptide of the tumor-shared antigen midkine hosts CD4+ T cell epitopesPleiotrophin fights Brd2 for neuronal differentiation.Midkine: an emerging target of drug development for treatment of multiple diseases.Periadolescent amphetamine treatment causes transient cognitive disruptions and long-term changes in hippocampal LTP depending on the endogenous expression of pleiotrophin.Development of inhibitors of receptor protein tyrosine phosphatase β/ζ (PTPRZ1) as candidates for CNS disorders.Increased serum midkine levels in autism spectrum disorder patients.Dienogest mediates midkine suppression in endometriosis.Exogenous midkine administration prevents cardiac remodeling in pacing-induced congestive heart failure of rabbits.The effect of midkine on growth factors and oxidative status in an experimental wound model in diabetic and healthy rats.Requirements for Neurogenin2 during mouse postnatal retinal neurogenesis
P2860
Q26778311-F0233263-6B19-40A0-8451-15152A68C7C4Q27005724-729EBA25-4D94-4097-A27F-F2B97EBEB345Q27013798-9BD74361-31E4-47A2-99AE-E25E0E3CBAE3Q27684027-D98DD60E-A02D-45A8-960B-E9B743E34F34Q28547212-AD4399E9-1A40-4E28-9965-F62FD5F5F9E6Q35027553-90ACC021-4B2A-43E7-9183-36C808577C31Q35077747-9D05509A-E86F-4488-8EDE-62BB2F153FEBQ35805773-6A1E7F7D-A514-46C5-B2CB-5E21703A0243Q35820040-3AB9C952-7CD5-4497-93B4-523332E70B1BQ36119574-8FEA9F0C-7778-4153-B746-B20CB721486FQ36253359-EBCA1FB9-F823-47AC-A7CC-D9EE2CA0C5E6Q36365202-3CF1FC42-EC17-4943-BBE2-D4367E5D86A4Q37274518-D006E0A4-5FDE-4BDD-B612-BED308587D4CQ37286279-27814D52-62FA-4F93-A9D5-95568963EBCDQ37585395-033C689D-9558-4690-9136-831112E71B74Q37585398-FAA1CA83-E74C-4652-A0E9-B5545FF9FB3FQ37585403-5BB614C5-66F2-4D5F-8ADC-42F503AE321BQ38124378-5F15F7F7-38B2-40A7-91A2-50180D00E8DEQ38181592-E3CEEE8A-A11D-4A15-A17D-3F4A7F1CA5B0Q38181600-FDE2F195-019A-47C9-8680-EF9A7EDDEA23Q38287940-775D88A5-0032-469B-AE88-51AF583BDAA8Q38293154-D1F370B4-6592-4244-A5EB-67CF7717A81AQ38294264-B4C2C854-3B09-42C6-B6E1-FB6DAF9473E5Q38760471-C6A4941C-3414-4A1C-8F3B-58366BA9CBAAQ39043765-94CC961E-C5DB-433E-8D04-D8813D583A74Q39171951-8AE319FA-9B63-4C74-9FBF-4DCB4FFC34E9Q40445200-D5D9B944-A57B-46BE-B5BE-C34193947070Q41844153-C60AD42A-887C-4AC3-8E5A-E4BA858B8334Q44466699-20D4B172-AFA7-4572-A488-CB3956E4ADEFQ47257582-38684801-B2FA-4FE8-87F3-CC794FB839F9Q47429837-F04D5A7C-CF76-43E6-8DCD-5A83A2750CA9Q47744086-B0EFD41D-1964-46F1-B88B-CC695212DDC4Q50461855-AA7E9489-2F8B-4AA3-8F29-1EC42395C7AEQ51146777-BC5AA522-19D5-499B-B52D-7AB7F2D845F4Q57462404-827E52FD-EEF4-4B47-A398-CD0332718E62
P2860
Midkine: a promising molecule for drug development to treat diseases of the central nervous system
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Midkine: a promising molecule ...... of the central nervous system
@ast
Midkine: a promising molecule ...... of the central nervous system
@en
type
label
Midkine: a promising molecule ...... of the central nervous system
@ast
Midkine: a promising molecule ...... of the central nervous system
@en
prefLabel
Midkine: a promising molecule ...... of the central nervous system
@ast
Midkine: a promising molecule ...... of the central nervous system
@en
P2860
P921
P1476
Midkine: a promising molecule ...... of the central nervous system
@en
P2093
Takashi Muramatsu
P2860
P304
P356
10.2174/138161211795164167
P5008
P577
2011-01-01T00:00:00Z